{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T13:44:46Z","timestamp":1705585486620},"reference-count":17,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1949,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1111\/j.1478-3231.2009.02196.x","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T18:10:20Z","timestamp":1261505420000},"page":"718-724","source":"Crossref","is-referenced-by-count":5,"title":["Models of influence in chronic liver disease"],"prefix":"10.1111","volume":"30","author":[{"given":"Amnon","family":"Sonnenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willscott E.","family":"Naugler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB1","doi-asserted-by":"crossref","unstructured":"1.\u2002 Sonnenberg A. Transposed Markov matrix as a new decision tool of how to choose among competing investment options in academic medicine. Comput Math Models Med 2009; 10: 1-7.","DOI":"10.1080\/17486700701865323"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB2","doi-asserted-by":"crossref","unstructured":"2.\u2002 Sonnenberg FA , Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13: 322-38.","DOI":"10.1177\/0272989X9301300409"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB3","volume-title":"Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine","author":"Petitti","year":"2000"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB4","volume-title":"Concepts in Probability and Stochastic Modeling","author":"Higgins","year":"1995"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB5","doi-asserted-by":"crossref","unstructured":"5.\u2002 Inadomi J , Sonnenberg A. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology 1997; 113: 1289-94.","DOI":"10.1053\/gast.1997.v113.pm9322524"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB6","unstructured":"6.\u2002 Spiegel BM , Targownik L , Dulai GS , Karsan HA , Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective? Hepatology 2003; 37: 366-77."},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB7","unstructured":"7.\u2002 Sonnenberg A , Derfus GA , Soergel KH. Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process. Dig Dis Sci 1991; 36: 949-56."},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB8","doi-asserted-by":"crossref","unstructured":"8.\u2002 Veenstra DL , Spackman DE , Di Bisceglie A , Kowdley KV , Gish RG. Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis. Aliment Pharmacol Ther 2008; 27: 1240-52.","DOI":"10.1111\/j.1365-2036.2008.03691.x"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u2002 Gerkens S , Nechelput M , Annemans L , et al. A health economic model to assess the cost-effectiveness of PEG IFN alpha-2a and ribavirin in patients with mild chronic hepatitis C. J Viral Hepat 2007; 14: 523-36.","DOI":"10.1111\/j.1365-2893.2006.00831.x"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB10","doi-asserted-by":"crossref","unstructured":"10.\u2002 Di Bisceglie AM , Shiffman ML , Everson GT , et al. H-CT Investigators. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 2008; 359: 2429-41.","DOI":"10.1056\/NEJMoa0707615"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u2002 Di Marco V , Almasio PL , Ferraro D , et al. Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial. J Hepatol 2007; 47: 484-91.","DOI":"10.1016\/j.jhep.2007.04.020"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB12","doi-asserted-by":"crossref","unstructured":"12.\u2002 Bruix J , Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.","DOI":"10.1002\/hep.20933"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB13","doi-asserted-by":"crossref","unstructured":"13.\u2002 Colombo M. Screening and diagnosis of hepatocellular carcinoma. Liver Int 2009; 29 (Suppl. 1): 143-7.","DOI":"10.1111\/j.1478-3231.2008.01938.x"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u2002 Ioannou GN , Splan MF , Weiss NS , et al. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 938-45, 945 e1-4.","DOI":"10.1016\/j.cgh.2007.02.039"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB15","volume-title":"Introduction to Stochastic Modeling","author":"Goodman","year":"2006"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB16","volume-title":"Applied Probability Models","author":"Minh","year":"2001"},{"key":"10.1111\/j.1478-3231.2009.02196.x-BIB17","volume-title":"Introduction to Probability Models","author":"Ross","year":"2006"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02196.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2009.02196.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:20:01Z","timestamp":1625664001000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02196.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02196.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}